Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression. - Wikidata - awgldk - TriplyDB

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.

http://www.wikidata.org/entity/Q35201636

about

A plasma cytokine and angiogenic factor (CAF) analysis for selection of bevacizumab therapy in patients with metastatic colorectal cancer Upfront molecular testing in patients with advanced gastro-esophageal cancer: Is it time yet?PKG II reverses HGF-triggered cellular activities by phosphorylating serine 985 of c-Met in gastric cancer cells.MET overexpression, gene amplification and relevant clinicopathological features in gastric adenocarcinoma.Hepatocyte growth factor/MET in cancer progression and biomarker discovery Emerging kinase inhibitors of the treatment of gastric cancer.Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis Clinical impact of high serum hepatocyte growth factor in advanced non-small cell lung cancer Expression of c-Met and hepatocyte growth factor in various gastric pathologies and its association with Helicobacter pylori infection.Biomarkers of gastric cancer: Current topics and future perspective Effect of fluorouracil, leucovorin, and oxaliplatin with or without onartuzumab in epidermal growth factor receptor-2-negative, mesenchymal-epithelial transition-positive gastroesophageal adenocarcinoma: is it a real failure?

P2860

Q36333585-181626F3-D09D-4D0A-96B7-8173415A0B07 Q36355920-7ED07DCC-92F2-4B70-A07B-876960FA11A7 Q37376230-81E6C714-D47E-4CA5-9C4D-0E55A8746838 Q37705824-DA1C23A6-715A-4629-82CB-F8F0D4508FE9 Q37735624-BEAEF92E-96B7-44DC-9EB1-23CC830EDBCF Q38506084-A8A18006-A53B-4214-8538-5ABD4D6F6DC5 Q42003695-0237B84F-DBA4-4276-BE1D-F05C58D52A53 Q42700876-4D06979D-88D1-4FBC-A01C-B9714D71CB39 Q47117947-EF713F80-5207-42C3-A4BA-4F76DC3EF2E9 Q57176090-21293CC7-E5BE-4B05-8FBB-CC3FEBD59AB4 Q58555802-0A8F48C9-B645-4D39-B508-38228F04E167

P2860

Clinical significance of hepatocyte growth factor/c-Met expression in the assessment of gastric cancer progression.

http://www.wikidata.org/entity/Q35201636

description

2015 nî lūn-bûn

@nan

2015 թուականի Յունուարին հրատարակուած գիտական յօդուած

@hyw

2015 թվականի հունվարին հրատարակված գիտական հոդված

@hy

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

name

Clinical significance of hepat ...... of gastric cancer progression.

@ast

Clinical significance of hepat ...... of gastric cancer progression.

@en

type

label

Clinical significance of hepat ...... of gastric cancer progression.

@ast

Clinical significance of hepat ...... of gastric cancer progression.

@en

prefLabel

Clinical significance of hepat ...... of gastric cancer progression.

@ast

Clinical significance of hepat ...... of gastric cancer progression.

@en

P1433

Q35201636-16BCD544-0B9D-4AC5-9833-B7316948C9F5

P1476

Q35201636-B01D4950-B727-4A65-AF67-0A3C65D7503C

P2093

Q35201636-051FDB0D-FA53-4627-B6F8-47AD7DD7BA56

Q35201636-0F8AFBEF-4482-49C2-A88F-2D5C4E1D208D

Q35201636-71A3B788-3EA9-46C9-B414-9F6113CE3C79

Q35201636-B15AADF7-1585-458B-9DBF-9E5D572606ED

P2860

Q35201636-06261C0E-030D-4592-AC8C-E8843929722C

Q35201636-16D762C2-9A35-4852-95B6-943DF6D59C18

Q35201636-1CCBAADB-01A3-433F-BA56-B57DB183AE85

Q35201636-1F16D803-D4CC-4280-9081-A82951C68B08

Q35201636-203A4DFD-00E5-4AFD-8A5A-842093B2A323

Q35201636-27682FAB-3EB4-44B1-A5EF-28997CA9E80D

Q35201636-2AD67AC2-C7FD-479D-8229-4253187AC95D

Q35201636-331C0BFD-08B9-40E4-A072-BF23C9DC0395

Q35201636-3AE1C6BE-999E-466C-BBDD-F9E1EB345935

Q35201636-407E2F7B-DFF3-49AF-9608-42246F77CA59

P304

Q35201636-97A47361-FE25-402E-92E9-EDA3B1ECE1B4

P31

Q35201636-F82E20C1-EB13-4AC1-94C2-7F78F9CEA444

P356

Q35201636-3B8B3BD6-34A8-4FF3-9881-EC89B525621C

P433

Q35201636-46E9B4C4-5A4B-49F9-81BB-4162AE4DBACF

P478

Q35201636-D9B2D4A2-4F96-428C-8537-0F416FC21ACB

P577

Q35201636-53950C4C-EA04-4CED-849A-163B881A15E9

P5875

Q35201636-B05EFDB5-D188-4869-A969-18183D470C4B

P698

Q35201636-821C1175-401B-4ABD-A730-3513AE23FCD9

P932

Q35201636-63AAFE22-E602-4B9D-980A-329D4425DE9A

P356

P1433

Molecular Medicine Reports

P1476

Clinical significance of hepat ...... of gastric cancer progression.

@en

P2093

Eiichiro Noguchi

http://www.w3.org/2001/XMLSchema#string

Makio Kobayashi

http://www.w3.org/2001/XMLSchema#string

Noboru Saito

http://www.w3.org/2001/XMLSchema#string

Shingo Kameoka

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and expression of human hepatocyte growth factor

Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product

Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor

Structure and function of hepatocyte growth factor

Sema4D induces angiogenesis through Met recruitment by Plexin B1

Rilotumumab in combination with epirubicin, cisplatin, and capecitabine as first-line treatment for gastric or oesophagogastric junction adenocarcinoma: an open-label, dose de-escalation phase 1b study and a double-blind, randomised phase 2 study.

c-Met as a target for human cancer and characterization of inhibitors for therapeutic intervention.

Activation of hepatocyte growth factor-met autocrine loop enhances tumorigenicity in a human lung adenocarcinoma cell line.

RON (MST1R) is a novel prognostic marker and therapeutic target for gastroesophageal adenocarcinoma.

Hepatocyte growth factor, its receptor, and their potential value in cancer therapies.

P304

3423-3431

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/MMR.2015.3205

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

11

http://www.w3.org/2001/XMLSchema#string

P577

2015-01-15T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

273310643

http://www.w3.org/2001/XMLSchema#string

P698

25592281

http://www.w3.org/2001/XMLSchema#string

P932

4368069

http://www.w3.org/2001/XMLSchema#string